7. Treatment of neuroendocrine tumours with high dose 131I-MIBG therapy
Jamshed BomanjiInstitute of Nuclear Medicine, andW. WongMeyerstein Institute of Oncology, The Middlesex Hospital, Mortimer Street, London, UKMark N. GazeMeyerstein Institute of Oncology, The Middlesex Hospital, Mortimer Street, London, UKA.M. CassoniMeyerstein Institute of Oncology, The Middlesex Hospital, Mortimer Street, London, UKWendy A. WaddingtonInstitute of Nuclear Medicine, andJosé SolanoMeyerstein Institute of Oncology, The Middlesex Hospital, Mortimer Street, London, UK
ABI
Annotatsiya
s of the 30th Annual Meeting of the British Nuclear Medicine Society Manchester, UK, 8-10 April 2002. Therapy
Mavzular
Identifikatorlar
Iqtiboslar va manbalar
0 ta iqtibos0 ta foydalanilgan manba
Koʻrsatkichlar — AkademScholar · Tez orada